Photo: Courtesy of Eli Lilly
A five-year dispute between Eli Lilly and Actavis over a cancer drug is being heard today at the UK Supreme Court.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
UK Supreme Court, Eli Lilly, Actavis, Alimta, patent, cancer treatment